• 1. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 2. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 3. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832

Recent Advances in the Study of 2-(2-Chloro-1,3-thiazol-5-yl)ethan-1-amine hydrochloride (CAS: 1803592-95-1)

In recent years, the compound 2-(2-Chloro-1,3-thiazol-5-yl)ethan-1-amine hydrochloride (CAS: 1803592-95-1) has garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its thiazole core and amine hydrochloride functionality, has shown promising potential in various therapeutic applications, including antimicrobial, antiviral, and anticancer activities. The unique structural features of this compound make it a valuable scaffold for drug discovery and development.

Recent studies have focused on elucidating the molecular mechanisms underlying the biological activities of 2-(2-Chloro-1,3-thiazol-5-yl)ethan-1-amine hydrochloride. For instance, a 2023 study published in the *Journal of Medicinal Chemistry* demonstrated its potent inhibitory effects against a range of Gram-positive and Gram-negative bacteria, with minimal cytotoxicity to human cells. The researchers attributed this selectivity to the compound's ability to disrupt bacterial cell wall synthesis, a mechanism distinct from traditional antibiotics.

In addition to its antimicrobial properties, this compound has also been investigated for its potential in antiviral therapy. A preprint article from *BioRxiv* (2024) highlighted its efficacy in inhibiting the replication of RNA viruses, including SARS-CoV-2, by targeting viral polymerase activity. These findings suggest that 2-(2-Chloro-1,3-thiazol-5-yl)ethan-1-amine hydrochloride could serve as a lead compound for the development of broad-spectrum antiviral agents.

Another area of active research involves the compound's application in oncology. Preliminary data from a collaborative study between academic and industry researchers (2024) revealed that derivatives of 2-(2-Chloro-1,3-thiazol-5-yl)ethan-1-amine hydrochloride exhibit selective cytotoxicity against cancer cell lines, particularly those with upregulated metabolic pathways. The compound's ability to modulate key signaling pathways, such as PI3K/AKT and MAPK, underscores its potential as a targeted therapy for certain cancers.

The synthesis and optimization of 2-(2-Chloro-1,3-thiazol-5-yl)ethan-1-amine hydrochloride have also been a focal point of recent research. Advances in green chemistry methodologies have enabled more efficient and sustainable production of this compound, as reported in a 2023 issue of *Organic Process Research & Development*. These innovations not only reduce environmental impact but also improve scalability for industrial applications.

Despite these promising developments, challenges remain in the clinical translation of 2-(2-Chloro-1,3-thiazol-5-yl)ethan-1-amine hydrochloride. Issues such as bioavailability, pharmacokinetics, and potential off-target effects need to be addressed through rigorous preclinical and clinical studies. However, the growing body of evidence supporting its therapeutic potential makes it a compelling candidate for further investigation.

In conclusion, 2-(2-Chloro-1,3-thiazol-5-yl)ethan-1-amine hydrochloride (CAS: 1803592-95-1) represents a versatile and promising molecule in the realm of chemical biology and drug discovery. Its diverse biological activities, coupled with advances in synthesis and optimization, position it as a valuable tool for addressing unmet medical needs. Future research should focus on overcoming translational barriers and exploring its full therapeutic potential.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)